Quantcast

CNN Proudly Declares Pfizer’s Bourla ‘Business CEO of the Year’

'Not only were we able to save so many lives, but we are enjoying high levels of corporate reputation right now. People like us... '

CNN has proudly declared their ally and business partner, Pfizer CEO Albert Bourla, the “Business CEO of the Year,” CNN reported.

In partnership with the big pharma giant, the mainstream media network has endlessly promoted Bourla’s jab, along with the many updated versions that he wishes to sell to the state as well.

“Bourla was our choice for all that Pfizer has done in a year where Covid vaccines went mainstream (vaccine was even named word of the year by Merriam-Webster) and helped stabilize America’s economy — and the world’s for that matter,” the network wrote.

The CEO himself admitted that he, also, was quite impressed with his work over the past two years.

...article continued below
- Advertisement -

Aside from saving millions of lives, Bourla credited himself with great popularity for the humanitarian sacrifices that he has made selling experimental jabs to the federal government.

“Pfizer did a lot of good [for] humanity and we are very, very proud of it,” Bourla said in an interview with CNN Business. “Not only were we able to save so many lives … but we are enjoying high levels of corporate reputation right now. People like us.”

Inspired by the financial success of the vaccine, Bourla praised himself for the development of pediatric jabs.

“We’re working very intensively on that to make sure we can bring a solution for that,” Bourla said.

...article continued below
- Advertisement -

“We are looking at different doses, well below the doses that have been used [for adults and older kids.] We know that it will be safe,” he added. “What we are looking to see is if that will protect them by giving the lower dose.”

On the subject of Pfizer’s new Omicron-specific designer vaccine, Bourla hurried to note that his company would not slow production of any of the previous vaccines, but would instead expand operations.

“We are aiming for a four billion [dose] annual manufacturing capacity of our current vaccine,” he said. “And if we have to switch between the two, the old and the new, we still will make four billion. We don’t expect that we will lose any volume.”

Pfizer generated $36 billion in revenue from the vaccine in 2021.

A good chunk of that loot, no doubt, went into sponsoring the same leftist media outfits that are now praising the unabashedly self-congratulatory CEO.

Copyright 2022. No part of this site may be reproduced in whole or in part in any manner without the permission of the copyright owner. To inquire about licensing content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -
- Advertisement -
- Advertisement -

TRENDING NOW

- Advertisement -
- Advertisement -

- Advertisement -